| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 896,151 | 910,154 | 861,981 | 812,941 | | Cost of Revenue | 259,315 | 286,585 | 275,633 | 280,814 | | | Gross Profit | 636,836 | 623,569 | 586,348 | 532,127 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 17,717 | 17,176 | 16,027 | 19,667 | | Non Recurring | 12,034 | (964) | 10,000 | (35,521) | | Others | 92,984 | 93,252 | 92,671 | 87,836 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 514,101 | 514,105 | 467,650 | 460,145 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,072 | 1,430 | 2,304 | 1,580 | | Earnings Before Interest And Taxes | 515,173 | 515,535 | 469,954 | 461,725 | | Interest Expense | 521 | 1,956 | 601 | 721 | | Income Before Tax | 514,652 | 513,579 | 469,353 | 461,004 | | Income Tax Expense | 100,357 | 95,012 | 86,831 | 85,286 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 414,295 | 418,567 | 382,522 | 375,718 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 414,295 | 418,567 | 382,522 | 375,718 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $414,295 | $418,567 | $382,522 | $375,718 |
|
0.45% Nasdaq 
0.20%
Income Statement
